Clinical Trial Update: Impact of Maternal-infant Therapeutics on Safety, Mortality, and Disability

View source ↗

Summary

A Duke University-sponsored clinical trial evaluating maternal-infant therapeutics for safety, mortality, and disability has been withdrawn; the listed conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Lung Disease
• Neurodevelopmental Impairment
• Patent Ductus Arteriosus
• Sepsis

Snippet

Sponsor: Duke University | Conditions: Gastroesophageal Reflux, Presumed Sepsis | Status: WITHDRAWN